The global Drug Delivery Devices market size was valued at US$ 46830 million in 2024 and is forecast to a readjusted size of USD 64720 million by 2031 with a CAGR of 4.8% during review period.
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world"s research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
This report is a detailed and comprehensive analysis for global Drug Delivery Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Delivery Devices market size and forecasts, in consumption value ($ Million), 2020-2031
Global Drug Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Drug Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Drug Delivery Devices market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Delivery Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD, Catalent, Valeant Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Drug Delivery Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Injection Type
Mucosal Type
Implanted Type
Others Type
麻豆原创 segment by Application
Pharmaceutical Companies
Hospitals
Clinics
Other
麻豆原创 segment by players, this report covers
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Delivery Devices, with revenue, gross margin, and global market share of Drug Delivery Devices from 2020 to 2025.
Chapter 3, the Drug Delivery Devices competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drug Delivery Devices market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Delivery Devices.
Chapter 13, to describe Drug Delivery Devices research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Drug Delivery Devices by Type
1.3.1 Overview: Global Drug Delivery Devices 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Drug Delivery Devices Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Injection Type
1.3.4 Mucosal Type
1.3.5 Implanted Type
1.3.6 Others Type
1.4 Global Drug Delivery Devices 麻豆原创 by Application
1.4.1 Overview: Global Drug Delivery Devices 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical Companies
1.4.3 Hospitals
1.4.4 Clinics
1.4.5 Other
1.5 Global Drug Delivery Devices 麻豆原创 Size & Forecast
1.6 Global Drug Delivery Devices 麻豆原创 Size and Forecast by Region
1.6.1 Global Drug Delivery Devices 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Drug Delivery Devices 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Drug Delivery Devices 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Drug Delivery Devices 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Drug Delivery Devices 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Drug Delivery Devices 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Drug Delivery Devices 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Cipla
2.1.1 Cipla Details
2.1.2 Cipla Major Business
2.1.3 Cipla Drug Delivery Devices Product and Solutions
2.1.4 Cipla Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Cipla Recent Developments and Future Plans
2.2 Baxter International
2.2.1 Baxter International Details
2.2.2 Baxter International Major Business
2.2.3 Baxter International Drug Delivery Devices Product and Solutions
2.2.4 Baxter International Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Baxter International Recent Developments and Future Plans
2.3 Nipro Corporation
2.3.1 Nipro Corporation Details
2.3.2 Nipro Corporation Major Business
2.3.3 Nipro Corporation Drug Delivery Devices Product and Solutions
2.3.4 Nipro Corporation Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Nipro Corporation Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Drug Delivery Devices Product and Solutions
2.4.4 Roche Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Roche Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Drug Delivery Devices Product and Solutions
2.5.4 Boehringer Ingelheim Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Drug Delivery Devices Product and Solutions
2.6.4 Allergan Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Allergan Recent Developments and Future Plans
2.7 3M
2.7.1 3M Details
2.7.2 3M Major Business
2.7.3 3M Drug Delivery Devices Product and Solutions
2.7.4 3M Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 3M Recent Developments and Future Plans
2.8 BD
2.8.1 BD Details
2.8.2 BD Major Business
2.8.3 BD Drug Delivery Devices Product and Solutions
2.8.4 BD Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 BD Recent Developments and Future Plans
2.9 Catalent
2.9.1 Catalent Details
2.9.2 Catalent Major Business
2.9.3 Catalent Drug Delivery Devices Product and Solutions
2.9.4 Catalent Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Catalent Recent Developments and Future Plans
2.10 Valeant Pharmaceuticals
2.10.1 Valeant Pharmaceuticals Details
2.10.2 Valeant Pharmaceuticals Major Business
2.10.3 Valeant Pharmaceuticals Drug Delivery Devices Product and Solutions
2.10.4 Valeant Pharmaceuticals Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Valeant Pharmaceuticals Recent Developments and Future Plans
2.11 Bayer AG
2.11.1 Bayer AG Details
2.11.2 Bayer AG Major Business
2.11.3 Bayer AG Drug Delivery Devices Product and Solutions
2.11.4 Bayer AG Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Bayer AG Recent Developments and Future Plans
2.12 Chiesi
2.12.1 Chiesi Details
2.12.2 Chiesi Major Business
2.12.3 Chiesi Drug Delivery Devices Product and Solutions
2.12.4 Chiesi Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Chiesi Recent Developments and Future Plans
2.13 Phillips-Medisize
2.13.1 Phillips-Medisize Details
2.13.2 Phillips-Medisize Major Business
2.13.3 Phillips-Medisize Drug Delivery Devices Product and Solutions
2.13.4 Phillips-Medisize Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Phillips-Medisize Recent Developments and Future Plans
2.14 Johnson & Johnson
2.14.1 Johnson & Johnson Details
2.14.2 Johnson & Johnson Major Business
2.14.3 Johnson & Johnson Drug Delivery Devices Product and Solutions
2.14.4 Johnson & Johnson Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Johnson & Johnson Recent Developments and Future Plans
2.15 Shandong Weigao
2.15.1 Shandong Weigao Details
2.15.2 Shandong Weigao Major Business
2.15.3 Shandong Weigao Drug Delivery Devices Product and Solutions
2.15.4 Shandong Weigao Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Shandong Weigao Recent Developments and Future Plans
2.16 Pfizer
2.16.1 Pfizer Details
2.16.2 Pfizer Major Business
2.16.3 Pfizer Drug Delivery Devices Product and Solutions
2.16.4 Pfizer Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Pfizer Recent Developments and Future Plans
2.17 B.Braun
2.17.1 B.Braun Details
2.17.2 B.Braun Major Business
2.17.3 B.Braun Drug Delivery Devices Product and Solutions
2.17.4 B.Braun Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 B.Braun Recent Developments and Future Plans
2.18 Novartis AG
2.18.1 Novartis AG Details
2.18.2 Novartis AG Major Business
2.18.3 Novartis AG Drug Delivery Devices Product and Solutions
2.18.4 Novartis AG Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Novartis AG Recent Developments and Future Plans
2.19 Zhengkang
2.19.1 Zhengkang Details
2.19.2 Zhengkang Major Business
2.19.3 Zhengkang Drug Delivery Devices Product and Solutions
2.19.4 Zhengkang Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.19.5 Zhengkang Recent Developments and Future Plans
2.20 Gerresheimer
2.20.1 Gerresheimer Details
2.20.2 Gerresheimer Major Business
2.20.3 Gerresheimer Drug Delivery Devices Product and Solutions
2.20.4 Gerresheimer Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.20.5 Gerresheimer Recent Developments and Future Plans
2.21 COVIDIEN Medtronic
2.21.1 COVIDIEN Medtronic Details
2.21.2 COVIDIEN Medtronic Major Business
2.21.3 COVIDIEN Medtronic Drug Delivery Devices Product and Solutions
2.21.4 COVIDIEN Medtronic Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.21.5 COVIDIEN Medtronic Recent Developments and Future Plans
2.22 Schott forma vitrum
2.22.1 Schott forma vitrum Details
2.22.2 Schott forma vitrum Major Business
2.22.3 Schott forma vitrum Drug Delivery Devices Product and Solutions
2.22.4 Schott forma vitrum Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.22.5 Schott forma vitrum Recent Developments and Future Plans
2.23 Alkermes
2.23.1 Alkermes Details
2.23.2 Alkermes Major Business
2.23.3 Alkermes Drug Delivery Devices Product and Solutions
2.23.4 Alkermes Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.23.5 Alkermes Recent Developments and Future Plans
2.24 Skyepharma
2.24.1 Skyepharma Details
2.24.2 Skyepharma Major Business
2.24.3 Skyepharma Drug Delivery Devices Product and Solutions
2.24.4 Skyepharma Drug Delivery Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.24.5 Skyepharma Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Drug Delivery Devices Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Drug Delivery Devices by Company Revenue
3.2.2 Top 3 Drug Delivery Devices Players 麻豆原创 Share in 2024
3.2.3 Top 6 Drug Delivery Devices Players 麻豆原创 Share in 2024
3.3 Drug Delivery Devices 麻豆原创: Overall Company Footprint Analysis
3.3.1 Drug Delivery Devices 麻豆原创: Region Footprint
3.3.2 Drug Delivery Devices 麻豆原创: Company Product Type Footprint
3.3.3 Drug Delivery Devices 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Drug Delivery Devices Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Drug Delivery Devices 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Drug Delivery Devices Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Drug Delivery Devices 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Drug Delivery Devices Consumption Value by Type (2020-2031)
6.2 North America Drug Delivery Devices 麻豆原创 Size by Application (2020-2031)
6.3 North America Drug Delivery Devices 麻豆原创 Size by Country
6.3.1 North America Drug Delivery Devices Consumption Value by Country (2020-2031)
6.3.2 United States Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Drug Delivery Devices Consumption Value by Type (2020-2031)
7.2 Europe Drug Delivery Devices Consumption Value by Application (2020-2031)
7.3 Europe Drug Delivery Devices 麻豆原创 Size by Country
7.3.1 Europe Drug Delivery Devices Consumption Value by Country (2020-2031)
7.3.2 Germany Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Devices Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Drug Delivery Devices Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Drug Delivery Devices 麻豆原创 Size by Region
8.3.1 Asia-Pacific Drug Delivery Devices Consumption Value by Region (2020-2031)
8.3.2 China Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Drug Delivery Devices Consumption Value by Type (2020-2031)
9.2 South America Drug Delivery Devices Consumption Value by Application (2020-2031)
9.3 South America Drug Delivery Devices 麻豆原创 Size by Country
9.3.1 South America Drug Delivery Devices Consumption Value by Country (2020-2031)
9.3.2 Brazil Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Devices Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Drug Delivery Devices Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Drug Delivery Devices 麻豆原创 Size by Country
10.3.1 Middle East & Africa Drug Delivery Devices Consumption Value by Country (2020-2031)
10.3.2 Turkey Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Drug Delivery Devices 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Drug Delivery Devices 麻豆原创 Drivers
11.2 Drug Delivery Devices 麻豆原创 Restraints
11.3 Drug Delivery Devices Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Drug Delivery Devices Industry Chain
12.2 Drug Delivery Devices Upstream Analysis
12.3 Drug Delivery Devices Midstream Analysis
12.4 Drug Delivery Devices Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
听
听
*If Applicable.
